American pharmaceutical giant Merck & Co. for years held offshore accounts in Bermuda to hold patents for two of its drugs, and then used the royalties from these patents as tax deductions in the United States. On Wednesday, the company agreed to pay $2.3 billion to the Internal Revenue Service, settling a three-year tax evasion…